Now Treating Prostate Cancer with Outpatient Ablation!

I am happy to announce that I have now partnered with Halo Precision Diagnostics to offer MRI-guided transurethral whole (or partial) gland ablations for prostate cancer using the TULSA device, developed by Profound Medical. This technique was recently featured on the cover of the Journal of Urology. Prostate ablation with TULSA is an outpatient procedure, with excellent treatment success and short recovery times for patients with lower grade disease, for salvage of radiation-recurrent disease, or for any patient seeking a treatment option that has substantially lower rates of side effects and risks. I previously developed one of the first TULSA centers in the USA in conjunction with the urologists at Yale, and currently I am the only one in the Boston area performing these procedures.